Alt tag

Vascular Adviser
for Healthcare Professionals

Coronary Artery Disease (CAD)

Video

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

What evidence drove the change in the ESC guidelines in CCS?

Jan Steffel on the new CCS Guidelines
PP-XAR-ALL-1436-1

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

What is new in the ESC guidelines?

Martin Cowie on the new CCS Guidelines
PP-XAR-ALL-1435-1

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

High-risk Subgroups in COMPASS, CAD Patients with Heart Failure

Kelley Branch on Treatment Strategies
PP-XAR-ALL-0820-1

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

High-risk Subgroups in COMPASS, Patients with risk of reinfarction

Treatment Strategy for Patients with Prior MI

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Evolving Management Strategies in CAD

Management strategies and unmet needs in coronary artery disease
PP-XAR-ALL-2002-1

 

Images

Thrombus in right atrial appendage

Atherothrombosis is a systemic disease

Atherothrombosis affects multiple arterial territories

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
arterial_segment_showing_a_vulnerable_plaque

Arterial segment showing a vulnerable plaque

Development of vulnerable plaques in arteries

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Atherosclerosis is a progressive disease

Atherosclerosis development

Atherosclerosis is a progressive disease

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Major modifiable and non-modifiable risk factors associated with cardiovascular disease

Major risk factors for cardiovascular disease

Major modifiable and non-modifiable risk factors associated with cardiovascular disease

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Risk factor profile and event rates in patients with coronary artery disease on the REACH registry

Risk factors and event rates in patients with CAD

Risk factor profile and event rates in patients with coronary artery disease on the REACH registry

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Secondary adverse CV events are associated with coronary syndromes

Patients with coronary syndrome can suffer a repeat adverse event

Secondary adverse CV events are associated with coronary syndromes

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Life expectancy is reduced in patients who have a history of cerebrovascular events and MI

Atherothrombosis reduces life expectancy

Life expectancy is reduced in patients who have a history of cerebrovascular events and MI

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Mortality rates in male and female patients with CVD are similar

Gender mortality rates are comparable between patients with CVD

Mortality rates in male and female patients with CVD are similar

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
The top ten causes of death worldwide

Coronary heart disease is a leading cause of death

The top ten causes of death worldwide

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Patients with CAD and ACS may experience a spectrum of conditions depending on the degree of stenosis and plaque characteristics

Coronary syndromes: Spectrum of conditions

Patients with CAD and ACS may experience a spectrum of conditions depending on the degree of stenosis and plaque characteristics

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Coronary ischaemia rapidly leads to myocardial injury and irreversible necrosis

Coronary artery thrombosis rapidly leads to myocardial ischaemia, injury and necrosis

Coronary ischaemia rapidly leads to myocardial injury and irreversible necrosis

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Recommended atherothrombotics used in the treatment of CAD and ACS. Acetylsalicylic acid is the preferred treatment for CAD but dual antiplatelet therapy is favourable for ACS...

Antiplatelet therapy used in the treatment of CAD and ACS

Recommended atherothrombotics used in the treatment of CAD and ACS. Acetylsalicylic acid is the preferred treatment for CAD but dual antiplatelet therapy is favourable for ACS...

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
The figure describes the prevalence of aspirin and other antithrombotic agents used among US patients enrolled in the REACH Registry

Antithrombotic agents prescribed to patients enrolled in the REACH Registry

The figure describes the prevalence of aspirin and other antithrombotic agents used among US patients enrolled in the REACH Registry

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Health burden of coronary heart disease is expected to increase as the population ages

Global health burden of coronary heart disease

Health burden of coronary heart disease is expected to increase as the population ages

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG
Patients with polyvascular disease have a higher risk of death and cardiovascular events than patients with single vessel disease

Morbidity and mortality rates in patients with polyvascular disease

Patients with polyvascular disease have a higher risk of death and cardiovascular events than patients with single vessel disease

Download

PDFPPTXDOCXXLSXMP4ZIPJPGPNG

Copyright © Bayer AG |

  • G.MKT.GM.XA.08.2017.1727

| Updated date 10/10/2022

La finalidad de este sitio web es proporcionar información al público internacional fuera de los EE. UU. y el Reino Unido.

Copyright © Bayer AG |

  • G.MKT.GM.XA.08.2017.1727

Updated date 10/10/2022

La finalidad de este sitio web es proporcionar información al público

internacional fuera de los EE. UU. y el Reino Unido.

Bayer Bayer

Síganos